0%

est. 2Y upside i

Series A

Stage: early. Country: England

Rank

#2146

Sector

Biomaterials

Est. Liquidity

~5Y

Data Quality

Data: Low

Quantitative analysis is not possible due to missing revenue and valuation data.

Last updated: July 19, 2026

Bull (0%)0%

Insufficient data to project

Base (0%)0%

Insufficient data to project

Bear (0%)0%

Insufficient data to project

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

0%

Total funding of $46.7M with unknown valuation; if valuation is ~$100M, preference overhang is ~47%, indicating severe risk for common stock.

Dilution Risk

high

Given early stage, additional rounds are likely, diluting common significantly.

Secondary Liquidity

none

No secondary market activity reported.

View all 3 open roles at PACT →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on PACT's data — designed to show you've done your homework.

  • 1

    “What is the current 409A valuation per share?”

  • 2

    “What is the current annual revenue run rate?”

  • 3

    “How many months of runway does the company have?”

Community

Valuation Sentiment

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.